Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane phospholipids and associated surfaces are essential structural and functional components of the lipid bilayer that surrounds the cytoplasm of bacteria and fungi. Unlike mammalian membranes, which are rich in neutral lipids like phosphatidylcholine and cholesterol, microbial membranes are characterized by a high proportion of anionic phospholipids such as phosphatidylglycerol and cardiolipin [3, 9]. These negatively charged surfaces, along with associated structures like lipopolysaccharides in Gram-negative bacteria, serve as the primary target for several classes of antibiotics, including polymyxins and lipopeptides like daptomycin [1, 6]. Interaction with these phospholipids leads to membrane depolarization, pore formation, and the catastrophic leakage of essential ions and metabolites, ultimately resulting in rapid cell death [4, 10]. Beyond their structural role, these phospholipids are involved in critical processes such as energy metabolism, cell signaling, and the coordination of cell division, making them a robust target for treating multidrug-resistant infections and biofilms [8, 14].
Drugs targeting microbial cell membrane phospholipids typically act by binding to anionic lipid headgroups, leading to membrane insertion, oligomerization, and the formation of transmembrane pores. This process causes rapid depolarization of the membrane potential, leakage of essential intracellular ions (such as potassium), and loss of osmotic integrity, which results in bactericidal or fungicidal activity [1, 3, 6].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane phospholipids and associated surfaces.